FEFettah Fevzi Ersoy

Fettah Fevzi Ersoy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fettah Fevzi Ersoy has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The association of vitamin D status with inflammatory parameters and proteinuria in patients with stage 3-5 chronic kidney disease who are not on renal replacement therapy

    by Hakan Doğruel, Feyza Bora, Fettah Fevzi Ersoy

    Amaç: Kronik böbrek hastalığı (KBH) ve proteinürisi olanlarda artmış oksidatif stres ve inflamasyonun kardiyovasküler morbidite ve mortalite ile ilişkili olduğu gösterilmiştir. Vitamin D’nin (VD) organizmada birçok rolünün olduğu son yıllarda VD reseptörünün çok sayıda dokuda gösterilmesiyle anlaşılmıştır. Bu çalışmada KBH olan bireylerde VD düzeyinin, inflamatuvar parametreler ve proteinüri ile ilişkisini değerlendirmeyi amaçladık. Gereç-Yöntem: Çalışmaya nefroloji polikliniğinde takip edilen ve henüz renal replasman tedavisi almamış, evre 3-5 KBH hastalar arasından dahil etme kriterlerini karşılayan 314 hasta alındı. Katılımcıların verileri retrospektif ve kesitsel olarak incelendi. Demografik özellikleri, kreatinin, tahmini glomerüler filtrasyon hızı (t GFH), serum 25(OH)D3, kalsiyum, albümin, fosfor, parathormon (PTH), spot idrarda protein/kreatinin oranı, nötrofil, lenfosit, platelet, nötrofil/lenfosit oranı (NLO) ve platelet/lenfosit oranı (PLO) kaydedildi. Serum 25(OH)D3 düzeyine göre; VD eksikliği olanlar, (29 ng/ml) olmak üzere 3 grup oluşturuldu. Gruplar, inflamatuvar parametreler ve proteinüri düzeyi yönünden karşılaştırıldı. Analizler SPSS 23.0 programı ile yapıldı. Bulgular: VD grupları arasında inflamatuvar parametreler (CRP, NLO ve PLO) açısından fark saptanmadı. Spot idrarda protein/kreatinin oranı VD eksikliği olanlarda, hem VD yetersizliği olanlardan (p:0, 007) hem de VD düzeyi normal olanlardan (p: 0,001) daha yüksekti. Ayrıca yapılan korelasyon analizinde VD düzeyi ile proteinüri arasında negative korelasyon saptandı (r: -267, p: <0,01). Nefrotik düzeyin altında proteinürisi olan bireylerde de VD düzeyi ve proteinüri ilişkisinin korunduğu saptandı (p: 0,018). Sonuç: Proteinüri düzeyinin, VD düzeyi ile negatif korelasyon gösterdiği ve VD eksikliği olanlarda daha yüksek değerlere ulaştığı görüldü. Bu noktada renal ve kardiyovasküler açıdan önemli bir faktör olan proteinürinin azaltılması noktasında VD’nin rolü gündeme gelebilir. Objective: It has been demonstrated that increased oxidative stress and inflammation are associated with increased cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD) and proteinuria. In recent years, it has been understood that vitamin D (VD) has many roles, with the demonstration of the VD receptor in many tissues. In this study, we aimed to evaluate the association of VD level with inflammatory parameters and proteinuria in individuals with CKD. Method: The study included 314 patients who were followed up in the nephrology outpatient clinic with the diagnosis of CKD, had not received renal replacement therapy yet and met the inclusion criteria. The data of the participants were analyzed retrospectively and cross-sectionally. Demographic characteristics, creatinine, estimated glomerular filtration rate, serum 25(OH)D3, calcium, albumin, phosphorus, parathormone (PTH), spot urine protein/creatinine ratio, neutrophil, lymphocyte, platelet, neutrophil/lymphocyte ratio (NLR) and platelet /lymphocyte ratio (PLR) were recorded. According to serum 25(OH)D3 level; Three groups were formed those with VD deficiency (29 ng/ml). The groups were compared in terms of inflammatory parameters and proteinuria levels. Analyzes were performed by using the SPSS 23.0 program. Results: There was no difference between the VD groups in terms of inflammatory parameters (CRP, NLR, and PLR). The protein/creatinine ratio in spot urine was higher in patients with VD deficiency than both those with VD insufficiency (p:0.007) and those with normal VD levels (p:0.001). In addition, a negative correlation was found between VD level and proteinuria (r: -267, p: <0.01). It was found that the association between VD level and proteinuria was preserved in individuals with proteinuria below the nephrotic level (p: 0.018). Conclusion: It was observed that the proteinuria level was negatively correlated with the VD level and reached higher values in those with VD deficiency. At this point, the role of VD in reducing proteinuria, which is an important factor in renal and cardiovascular terms, may become a current issue.

  • A case of cyclic hemoperitoneum in a hemodialysis patient: Encapsulated peritoneal sclerosis complicated by endometriosis and fungal peritonitis

    by Fatih Yılmaz, Feyza Bora, Ramazan Çetinkaya, Mustafa Tekinalp Gelen, Gültekin Süleymanlar, Fevzi Ersoy

    Encapsulated peritoneal sclerosis (EPS) is a rare, but frequently fatal, long‐term complication of peritoneal dialysis. Endometriosis is a common gynecological problem but hemoperitoneum due to endometriosis has been reported to be extremely rare in hemodialysis (HD) patients. A 25‐year‐old female HD patient was admitted to our clinic with nausea, vomiting, abdominal pain, and weight loss for last 3 months. Candida tropicalis and Candida glabrata were isolated in the fungal cultures from peritoneal fluid. Her abdominal computerized tomography scan has shown irregular peritoneal calcifications, diffuse peritoneal thickening, dilatation of the small bowel loops, and cocoon formation which all were typical for EPS. Hemoperitoneum was reported to recur for four times with intervals suggesting menstrual cycles. Her peritoneal biopsy, along with the signs of EPS, has also revealed the presence of endometriosis. The patient died with symptoms of septic shock in the first year of EPS diagnosis.


  • Lymphocyte and monocyte vitamin D receptor expression during paricalcitol or calcitriol treatments in patients with stage 5 chronic kidney disease

    by Hasan Sözel, Sadi Köksoy, Sebahat Ozdem, Fatih Yılmaz, Feyza Bora, F. Fevzi Ersoy

    Purpose In this study, we aimed to investigate the effect of paricalcitol and calcitriol usage on vitamin D receptor (VDR) contents of CD8+ , CD4+ lymphocytes and monocytes in stage 5d chronic kidney disease (CKD) patients. Methods Thirty-six hemodialysis patients older than 18 years of age and 19 healthy controls (group HC) without any known acute or chronic diseases were included in the study. The group of patients undergoing scheduled hemodialysis comprised three subgroups: group CL: patients on calcitriol (n: 10), group PC: patients on paricalcitol (n: 13), and group NT: patients not taking any vitamin D or VDR activating medications (n: 13). CD8+/VDR, CD4+/VDR and MONO/VDR values were representing the ratio of VDR representing cells among related cell group. On the other hand, values of CD8+/MFI, CD4+/MFI and MONO/MFI have shown the total amount of cellular VDR content per cell which has been given as of mean fluorescence intensity in the flow cytometric process. Main CKD mineral bone disorder parameters such as a hemogram, serum BUN, creatinine, albumin, Ca, iP, iPTH, 25(OH)D3 levels were also measured. Results Average VDR contents in CD8+, CD4+ and monocytes were not different among three patient groups on hemodialysis. But in all hemodialysis subgroups, CD8+/VDR, CD4+/VDR, MONO/VDR, CD8+/MFI, CD4+/MFI and MONO/MFI levels were found to be higher compared with the healthy control subjects (p < 0.001). Among hemodialysis groups, no significant CD8+/VDR, CD4+/VDR, and MONO/VDR content differences were found with regard to the type of VDR activator agent used. There was no difference in serum levels of 25(OH)D3 and CRP among groups participating in the study. Conclusion There was no difference between CD8+/VDR, CD4+/VDR, and MONO/VDR levels in hemodialysis patients using calcitriol or paricalcitol, suggesting that both treatment agents may have a similar effect on VDR contents in lymphocytes and monocytes in that patient population. But in all hemodialysis subgroups, CD8+/VDR, CD4+/VDR, and MONO/VDR levels were found to be higher compared with the healthy control subjects, suggesting an overexpression of VDR through a non CRP and/or 25(OH)D3 dependent mechanism.


  • Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study

    by Hasan Koc, Hasan Hoser, Yalcin Akdag, Cemaliye Kendir, F. Fevzi Ersoy

    To evaluate monthly percentage changes of intact parathyroid hormone (iPTH) and other major bone marker levels in patients with secondary hyperparathyroidism (SHPT) undergoing hemodialysis (HD) and receiving paricalcitol.


  • Open Access

    Comparison of Calcineurin Inhibitors with M-Tor Inhibitors in Renal Transplant Patients

    by Vural Taner Yılmaz, Hüseyin Koçak, Ayhan Dinçkan, Ramazan Çetinkaya, F. Fevzi Ersoy, Gültekin Süleymanlar

  • Bone Health and Renal Replacement Therapies: Which are the Best?

    by Vural Taner Yılmaz, Sebahat Özdem, Levent Dönmez, Ramazan Çetinkaya, Gültekin Süleymanlar, F. Fevzi Ersoy

  • Open Access

    FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients

    by Vural Taner Yilmaz, Sebahat Ozdem, Levent Donmez, Ramazan Cetinkaya, Gultekin Suleymanlar, F. Fevzi Ersoy

    Amaç: Çalışmamızda kronik periton diyalizi (KPD) hastalarında klotho gen polimorfizmi (KGP) ve kemik mineral yoğunluğu (KMY) ile bazı major kemik metabolizma belirteçleri arasındaki ilişkinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Çalışmaya dahil edilen 51 KPD hastası ve 40 sağlıklı kontrol grubunda intakt parathormon (iPTH), fibroblast büyüme faktör (FGF-23), osteoprotogerin (OPG), osteokalsin (OK), prokollajen tip-1 N terminal propeptid (PINP), beta- crosslaps (beta KTx), tartarate resistan asid fosfataz (TRAF5b), kemik alkalen fosfataz (KAF), 1,25(OH)D3, 25(OH)D3 ve a-klotho gen mutasyonları ölçüldü. Bulgular: 51 KPD hastasında 1,25(OH)D3 ve 25(OH)D3 eksikliği oranı sırasıyla %96 ve %94 olarak tespit edildi. iPTH (249 pg/mL ve 39 pg/mL) ve FGF-23 (1089 RU/mL ve 153 RU/mL), OPG, OK, PINP, beta CTx, TRAP5b seviyeleri hastalarda istatistiksel olarak anlamlı derecede daha yüksek bulundu. Hastalarda iPTH seviyeleri ve tüm vücut KMY arasında negatif korelasyon tespit edildi. KGP oranı gruplar arasında benzer bulundu. Sonuç: Kronik periton diyalizi hastalarında D vitamin eksikliğine ek olarak, OPG, OK, PINP, beta CTx, TRAP5b düzeyleri yüksek saptandı. iPTH seviyeleri ile KAF ve PINP arasındaki pozitif korelasyon bu belirteçlerin kronik böbrek hastalarındaki (KBH) kemik mineral hastalıklarının (KMH) tedavisinde tanısal değerinin olduğunu göstermiştir. Diğer taraftan yüksek serum TRAP5b konsantrasyonunun kalsitriol tedavisi ve hiperparatiroidinin şiddetinden etkilenmediği de gösterilmiştir. iPTH ve FGF-23 düzeyleri ile tüm vücut KMY arasında anlamlı negatif korelasyon tespit edilmiştir. Çalışmamızda klotho gen polimorfizmi ile KBH-KMH’nın hiçbir belirteci arasında anlamlı korelasyon gösterilememiştir.


  • A short story of Klotho and FGF23: a deuce of dark side or the savior?

    by F. Fevzi Ersoy

    Fibroblast growth factor 23 (FGF23) is an osteocyte and osteoblast derived peptide hormone, which requires Klotho as a cofactor for its biologic actions. FGF23 acts as a phosphaturic agent and it is capable of reducing serum inorganic phosphate (Pi) via direct inhibition of renal NaPi-2a transporter in the proximal tubuli, as well as indirectly, via the suppression of calcitriol synthesis. In patients with chronic kidney disease (CKD), circulating FGF23 levels are markedly elevated, while Klotho production is decreased. Experimental observations indicating that lack of activities of both Klotho and FGF23 may cause decreased life span, premature aging and accelerated atherosclerosis and generalized vascular calcifications have raised the question whether FGF23 could be a new risk factor and predictor of cardiovascular (CV) disease in both renal and non-renal patient groups. Clinical studies, however, have yielded conflicting results. Some of these studies have found that serum FGF23 is independently associated with mortality and CV events in CKD patients, while others have failed to show any relationship. Furthermore, some studies have even suggested that FGF23 may have a protective role against vascular calcifications and CV disease. Thus, there is clearly a need for further research in this area, and special interest should be paid to the physiologic consequences of high FGF23/low Klotho state, which is typical for patients with CKD.


  • Peripheral Treg count and it’s determinants in unsensitized and sensitized chronic kidney disease patients

    by Cansu Topal, Sadi Köksoy, Gültekin Süleymanlar, Gülşen Yakuboğlu, F. Fevzi Ersoy

    Purpose Sensitization to HLA antigens resulting in anti-HLA antibodies (panel reactive antibodies; PRA) is a major problem in chronic kidney disease (CKD) patients awaiting transplantation. Induction of anti-HLA antibodies normally occurs through blood transfusion, pregnancy and prior transplantation. However, some patients develop these antibodies for unknown immunological reasons. It is hypothesized that deviations in immune regulation may account for PRA positivity in these patients. We, therefore, investigated whether a quantitative deficiency in peripheral natural regulatory T cells (CD4+CD25highFoxp3+; nTreg) plays a role in this phenomenon. Methods Peripheral blood mononuclear cells from 14 patients with positive (Class I and Class II; 10–100 %) and 25 patients with negative PRA, who had not previously been sensitized by blood transfusion, pregnancy and prior transplantation and who had not received any immunomodulatory treatment within the last year, were analyzed for absolute lymphocyte and nTreg numbers through flow cytometry. Samples from 10 healthy people were also used as control. Results Mean absolute nTreg numbers were determined to be severely reduced in CKD patients (12 ± 9; n = 39) compared with healthy individuals (53 ± 17; n = 10) (p = 0.008). However, absolute nTreg numbers were similar between PRA− (12 ± 11) and PRA+ (11 ± 8) groups. Interestingly, there was a moderate correlation between the nTreg numbers and HLADR2 genotype (n = 9, r = 0.508, p < 0.05). Conclusion This is the first study to demonstrate that the quantitative peripheral nTreg deficiency in CKD patients does not show a causal relationship with the presence of anti-HLA antibodies.